Inhibitory effect of matrine on the expression of PSA and AR in prostate cancer cell line LNCaP
Ke Chen(Merck & Co., Inc., Rahway, NJ, USA (United States)), Zhangqun Ye(Tongji Hospital), Zhiquan Hu(Union Hospital), Tao Wang(Tongji Hospital), Hui Guo(First Affiliated Hospital of Xi'an Jiaotong University)
Journal of Huazhong University of Science and Technology [Medical Sciences]
December 1, 2008
Cited by 6
Related Papers
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
|ACS Pharmacology & Translational Science|2020|225
Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles
|ACS Pharmacology & Translational Science|2020|128
Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
|Molecular Therapy|2020|127
Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer
|Clinical Cancer Research|2016|125